Wednesday, July 1, 2015

British Journal of Cancer - Table of Contents alert Volume 113 Issue 1

If you are unable to see the message below, click here to view.
British Journal of Cancer

TABLE OF CONTENTS

Volume 113, Issue 1 (1-192)
Published online 30 June 2015

In this issue
Minireview
Review
Clinical Studies
Translational Therapeutics
Molecular Diagnostics
Epidemiology

Also new today
Advance online publication
Digital Edition
Sign up for e-alerts Sign up for e-alerts
Recommend to your library
Web feed
Subscribe

Minireview

Top

Stem vs non-stem cell origin of colorectal cancer

D J Huels and O J Sansom

Br J Cancer 2015 113: 1-5; advance online publication, June 25, 2015; 10.1038/bjc.2015.214

Abstract | Full Text

Review

Top

Best supportive care in clinical trials: review of the inconsistency in control arm design

R D Nipp, D C Currow, N I Cherny, F Strasser, A P Abernethy and S Y Zafar

Br J Cancer 2015 113: 6-11; advance online publication, June 11, 2015; 10.1038/bjc.2015.192

Abstract | Full Text

Clinical Studies

Top

Final results from the large sunitinib global expanded-access trial in metastatic renal cell carcinoma

M E Gore, C Szczylik, C Porta, S Bracarda, G A Bjarnason, S Oudard, S-H Lee, J Haanen, D Castellano, E Vrdoljak, P Schöffski, P Mainwaring, R E Hawkins, L Crinò, T M Kim, G Carteni, W E E Eberhardt, K Zhang, K Fly, E Matczak, M J Lechuga, S Hariharan and R Bukowski

Br J Cancer 2015 113: 12-19; advance online publication, June 18, 2015; 10.1038/bjc.2015.196

Abstract | Full Text

Survival, quality-adjusted survival, and other clinical end points in older advanced non-small-cell lung cancer patients treated with albumin-bound paclitaxel

C J Langer, V Hirsh, I Okamoto, F-J Lin, Y Wan, S Whiting, T J Ong, M F Renschler and M F Botteman

Br J Cancer 2015 113: 20-29; advance online publication, June 2, 2015; 10.1038/bjc.2015.181

Abstract | Full Text

Time-varying effect and long-term survival analysis in breast cancer patients treated with neoadjuvant chemotherapy

S Baulies, L Belin, P Mallon, C Senechal, J-Y Pierga, P Cottu, M-P Sablin, X Sastre, B Asselain, R Rouzier and F Reyal

Br J Cancer 2015 113: 30-36; advance online publication, June 16, 2015; 10.1038/bjc.2015.174

Abstract | Full Text

Translational Therapeutics

Top

Vascular endothelial growth factor D expression is a potential biomarker of bevacizumab benefit in colorectal cancer

A J Weickhardt, D S Williams, C K Lee, F Chionh, J Simes, C Murone, K Wilson, M M Parry, K Asadi, A M Scott, C J A Punt, I D Nagtegaal, T J Price, J M Mariadason and N C Tebbutt

Br J Cancer 2015 113: 37-45; advance online publication, June 30, 2015; 10.1038/bjc.2015.209

Abstract | Full Text

Hypoxia-activated chemotherapeutic TH-302 enhances the effects of VEGF-A inhibition and radiation on sarcomas

C Yoon, H-J Lee, D J Park, Y-J Lee, W D Tap, T S K Eisinger-Mathason, C P Hart, E Choy, M C Simon and S S Yoon

Br J Cancer 2015 113: 46-56; advance online publication, May 26, 2015; 10.1038/bjc.2015.186

Abstract | Full Text

Molecular Diagnostics

Top

Augmented expression of MYC and/or MYCN protein defines highly aggressive MYC-driven neuroblastoma: a Children’s Oncology Group study

L L Wang, R Teshiba, N Ikegaki, X X Tang, A Naranjo, W B London, M D Hogarty, J M Gastier-Foster, A T Look, J R Park, J M Maris, S L Cohn, R C Seeger, S Asgharzadeh and H Shimada

Br J Cancer 2015 113: 57-63; advance online publication, June 2, 2015; 10.1038/bjc.2015.188

Abstract | Full Text

Validation of histomolecular classification utilizing histological subtype, MUC1, and CDX2 for prognostication of resected ampullary adenocarcinoma

A Schueneman, M Goggins, J Ensor, B Saka, N Neishaboori, S Lee, A Maitra, G Varadhachary, N Rezaee, C Wolfgang, V Adsay, H Wang and M J Overman

Br J Cancer 2015 113: 64-68; advance online publication, May 19, 2015; 10.1038/bjc.2015.172

Abstract | Full Text

Differential p16/INK4A cyclin-dependent kinase inhibitor expression correlates with chemotherapy efficacy in a cohort of 88 malignant pleural mesothelioma patients

C J Jennings, B Murer, A O'Grady, L M Hearn, B J Harvey, E W Kay and W Thomas

Br J Cancer 2015 113: 69-75; advance online publication, June 9, 2015; 10.1038/bjc.2015.187

Abstract | Full Text

Circulating microRNAs as prognostic therapy biomarkers in head and neck cancer patients

I Summerer, K Unger, H Braselmann, L Schuettrumpf, C Maihoefer, P Baumeister, T Kirchner, M Niyazi, E Sage, H M Specht, G Multhoff, S Moertl, C Belka and H Zitzelsberger

Br J Cancer 2015 113: 76-82; advance online publication, June 9, 2015; 10.1038/bjc.2015.111

Abstract | Full Text

MiR-320e is a novel prognostic biomarker in colorectal cancer

L Perez-Carbonell, F A Sinicrope, S R Alberts, A L Oberg, F Balaguer, A Castells, C R Boland and A Goel

Br J Cancer 2015 113: 83-90; advance online publication, June 2, 2015; 10.1038/bjc.2015.168

Abstract | Full Text

SNPs at miR-155 binding sites of TYRP1 explain discrepancy between mRNA and protein and refine TYRP1 prognostic value in melanoma

P El Hajj, D Gilot, M Migault, A Theunis, L C van Kempen, F Salés, H Fayyad-Kazan, B Badran, D Larsimont, A Awada, L Bachelot, M-D Galibert, G Ghanem and F Journe

Br J Cancer 2015 113: 91-98; advance online publication, June 11, 2015; 10.1038/bjc.2015.194

Abstract | Full Text

High leukocyte mitochondrial DNA content contributes to poor prognosis in glioma patients through its immunosuppressive effect

Y Chen, J Zhang, X Huang, J Zhang, X Zhou, J Hu, G Li, S He and J Xing

Br J Cancer 2015 113: 99-106; advance online publication, May 28, 2015; 10.1038/bjc.2015.184

Abstract | Full Text

Systematic review and meta-analysis of immunohistochemical prognostic biomarkers in resected oesophageal adenocarcinoma

L H McCormick Matthews, F Noble, J Tod, E Jaynes, S Harris, J N Primrose, C Ottensmeier, G J Thomas and T J Underwood

Br J Cancer 2015 113: 107-118; advance online publication, June 25, 2015; 10.1038/bjc.2015.179

Abstract | Full Text

Epidemiology

Top

Colposcopy attendance and deprivation: A retrospective analysis of 27193 women in the NHS Cervical Screening Programme

E Douglas, J Wardle, N J Massat and J Waller

Br J Cancer 2015 113: 119-122; advance online publication, May 21, 2015; 10.1038/bjc.2015.176

Abstract | Full Text

Post-diagnostic oral bisphosphonate use and colorectal cancer mortality: a population-based cohort study within the UK Clinical Practice Research Datalink

B M Hicks, L J Murray, C Hughes and C R Cardwell

Br J Cancer 2015 113: 123-126; advance online publication, May 19, 2015; 10.1038/bjc.2015.152

Abstract | Full Text

Diabetes mellitus and the risk of bladder cancer: an Italian case–control study

F Turati, J Polesel, M Di Maso, M Montella, M Libra, M Grimaldi, A Tavani, D Serraino, C La Vecchia and C Bosetti

Br J Cancer 2015 113: 127-130; advance online publication, May 21, 2015; 10.1038/bjc.2015.178

Abstract | Full Text

Increasing incidence of base of tongue cancers from 2000 to 2010 due to HPV: the largest demographic study of 210 Danish patients

E Garnaes, K Kiss, L Andersen, M H Therkildsen, M B Franzmann, B Filtenborg-Barnkob, E Hoegdall, C B Lajer, E Andersen, L Specht, L Joenson, K Frederiksen, L Friis-Hansen, F C Nielsen, S K Kjaer, B Norrild and C von Buchwald

Br J Cancer 2015 113: 131-134; advance online publication, June 4, 2015; 10.1038/bjc.2015.198

Abstract | Full Text

Modelling the cost-effectiveness of public awareness campaigns for the early detection of non-small-cell lung cancer

S Hinde, C McKenna, S Whyte, M D Peake, M E J Callister, T Rogers and M Sculpher

Br J Cancer 2015 113: 135-141; advance online publication, May 26, 2015; 10.1038/bjc.2015.167

Abstract | Full Text

Likely effect of adding flexible sigmoidoscopy to the English NHS Bowel Cancer Screening Programme: impact on colorectal cancer cases and deaths

S M E Geurts, N J Massat and S W Duffy

Br J Cancer 2015 113: 142-149; advance online publication, June 25, 2015; 10.1038/bjc.2015.76

Abstract | Full Text

Utility of pre-treatment neutrophil–lymphocyte ratio and platelet–lymphocyte ratio as prognostic factors in breast cancer

C-H Koh, N Bhoo-Pathy, K-L Ng, R S Jabir, G-H Tan, M-H See, S Jamaris and N A Taib

Br J Cancer 2015 113: 150-158; advance online publication, May 28, 2015; 10.1038/bjc.2015.183

Abstract | Full Text

Background risk of breast cancer influences the association between alcohol consumption and mammographic density

T Trinh, S E Christensen, J S Brand, J Cuzick, K Czene, A Sjölander, K Bälter and P Hall

Br J Cancer 2015 113: 159-165; advance online publication, June 2, 2015; 10.1038/bjc.2015.185

Abstract | Full Text

An analysis of the association between prostate cancer risk loci, PSA levels, disease aggressiveness and disease-specific mortality

J Sullivan, R Kopp, K Stratton, C Manschreck, M Corines, R Rau-Murthy, J Hayes, A Lincon, A Ashraf, T Thomas, K Schrader, D Gallagher, R Hamilton, H Scher, H Lilja, P Scardino, J Eastham, K Offit, J Vijai and R J Klein

Br J Cancer 2015 113: 166-172; advance online publication, June 11, 2015; 10.1038/bjc.2015.199

Abstract | Full Text

Cancer survival differences between South Asians and non-South Asians of England in 1986–2004, accounting for age at diagnosis and deprivation

C Maringe, R Li, P Mangtani, M P Coleman and B Rachet

Br J Cancer 2015 113: 173-181; advance online publication, June 16, 2015; 10.1038/bjc.2015.182

Abstract | Full Text

Vitamin E intake from natural sources and head and neck cancer risk: a pooled analysis in the International Head and Neck Cancer Epidemiology consortium

V Edefonti, M Hashibe, M Parpinel, M Ferraroni, F Turati, D Serraino, K Matsuo, A F Olshan, J P Zevallos, D M Winn, K Moysich, Z-F Zhang, H Morgenstern, F Levi, K Kelsey, M McClean, C Bosetti, S Schantz, G-P Yu, P Boffetta, S-C Chuang, Y-C A Lee, C La Vecchia and A Decarli

Br J Cancer 2015 113: 182-192; advance online publication, May 19, 2015; 10.1038/bjc.2015.149

Abstract | Full Text

Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to British Journal of Cancer. In order to do so, please purchase a subscription.

You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant).

For further technical assistance, please contact our registration department.

For print subscription enquiries, please contact our subscription department.

For other enquiries, please contact our customer feedback department.

Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA

Nature Publishing Group's worldwide offices:
London - Paris - Munich - New Delhi - Tokyo - Melbourne
San Diego - San Francisco - Washington - New York - Boston

Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS.

© 2015 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.

nature publishing group
 

No comments: